AMAG Pharmaceuticals Inc (AMAG) - Pharmaceuticals & Healthcare – market overview.

HTF Market Intelligence released a new research report of 46 pages on title ‘AMAG Pharmaceuticals Inc (AMAG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile’  with detailed analysis, forecast and strategies.

Summary

AMAG Pharmaceuticals Inc (AMAG) is a specialty pharmaceutical company that carries out development and commercialization of specialty pharmaceutical products. The company focuses on maternal health, anemia management and cancer supportive care. The company offers wide range of products and services that includes hydroxyprogesterone caproate injection; collection, processing and storage related services of umbilical cord blood stem cell and cord tissue units; intravenous injection and Mucoadhesive Oral Wound Rinse. AMAG offers these products through both direct sales and through network of distributors. The company has operations in the US and the UK through its subsidiaries. AMAG is headquartered in Waltham, Massachusetts, the US.

AMAG Pharmaceuticals Inc (AMAG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

Request a sample report @ https://www.htfmarketreport.com/sample-report/238349-amag-pharmaceuticals-inc-2

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description – A brief description of the company’s operations.

- Key Employees – A list of the key executives of the company.

- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors – A list of the key competitors of the company.

- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements

- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy

- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Make an enquiry before buying this Report @ https://www.htfmarketreport.com/enquiry-before-buy/238349-amag-pharmaceuticals-inc-2

Table of Contents 

Table of Contents  2

List of Tables  4

List of Figures  5

AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017  6

AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017  7

AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017  8

AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017  9

AMAG Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017  11

AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017  12

AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details  14

Asset Purchase  14

AMAG Pharma Enters into Option Agreement to Acquire Rights of Orphan Drug Candidate from Velo Bio  14

KV Pharma Acquires Rights To Makena From Hologic For US$199.5 Million  15

Private Equity  16

GTCR Invests In Cord Blood Registry  16

MSMB Capital Management To Acquire AMAG Pharma  17

Partnerships  18

Cord Blood Registry Enters into Research Agreement with Cellular Dynamics  18

Licensing Agreements  19

AMAG Pharma and Endoceutics to Enter Licensing Agreement  19

AMAG Ph

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/238349-amag-pharmaceuticals-inc-2

Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=238349

Contact Us:

CRAIG FRANCIS (PR & Marketing Manager)

[email protected]

Ph: +1 (206) 317 1218